BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, today announced that it will release financial results for the second quarter ended June 30, 2022 before the open of trading on Thursday, August 4. Biodesix’s management will host a conference call and webcast to discuss … [Read more…]
‘No hospitalizations. No nearest. No excuses.’ WEST PALM BEACH, Fla.–(BUSINESS WIRE)–#covid19—Covac Global, the Premier Medical Evacuation Membership, pioneered the simple approach to medical evacuation with “Get Sick, Get Home” requiring no hospitalization, announces it will include repatriation for monkeypox to complement their pioneering medical evacuation memberships – regardless of the location of a traveler’s injury … [Read more…]
BURNABY, British Columbia–(BUSINESS WIRE)–Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (rtCGM), is proud to announce that it is certified as a Great Place to Work® in Canada for 2022-23. Awarded by Great Place to Work Institute® Canada, the global authority on high-trust, high-performance workplace cultures, this prestigious certification is based on … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “US Medical Imaging Lens Market (2022-2027) by Product Application, Functional Application, End-Users, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The US Medical Imaging Lens Market is estimated to be USD 90.77 Mn in 2022 and is projected to reach USD 131.96 Mn by … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Cardiomyopathies Epidemiology Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering. The report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of these cardiomyopathies segmented by subtype, sex, and age (under 18 years, 18-29 years, and by 10-year age groups for ages 30 years up to 80 years and older) in … [Read more…]
VIENNA, Austria–(BUSINESS WIRE)–Ribbon Biolabs, the DNA synthesis company, today announced that the U.S. Patent and Trademark Office has issued U.S. Patent US 2020283756 A1, covering Ribbon Biolabs’ novel method for synthesizing a double stranded polynucleotide, also known as DNA, using a diverse library of oligonucleotides. The patent is the first of its submitted patent applications … [Read more…]
State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for Organ-on-a-Chip research services CAMBRIDGE, England–(BUSINESS WIRE)–CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services. The Company’s laboratory space … [Read more…]
The test will be the first in a pipeline of affordable, portable, easy-to-use, graphene-based IVD products, which will at least match the performance of the most advanced hospital laboratory, but at the point of care. CAMBRIDGESHIRE, England–(BUSINESS WIRE)–Paragraf, the first company in the world to deliver a scalable approach to graphene electronic device manufacturing, announces … [Read more…]
Approval broadens indication for Daiichi Sankyo and AstraZeneca’s ENHERTU across Europe to earlier use in HER2 positive metastatic breast cancer Based on groundbreaking DESTINY-Breast03 results in which ENHERTU demonstrated a 72% reduction in the risk of disease progression or death vs. trastuzumab emtansine (T-DM1) TOKYO & MUNICH, Germany–(BUSINESS WIRE)–Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: … [Read more…]
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that a phase III clinical trial for SINOVAC’s inactivated quadrivalent influenza vaccine was initiated in the Republic of Chile through a collaboration with the Pontificia Universidad Católica de Chile (PI Dr. Pablo González). Study results will … [Read more…]
